Naziri Alireza, Motevali-Haghi Afsaneh, Nateghpour Mehdi, Shabani Mohammad, Dehdast S Ahmad, Rahimi-Foroushani Abbas, Khezri Aram, Farzaneh Zahra
Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran.
J Arthropod Borne Dis. 2024 Sep 30;18(3):264-275. doi: 10.18502/jad.v18i3.18577. eCollection 2024 Sep.
The global rise in malaria parasite resistance to antimalarial drugs necessitates new therapeutic strategies. Medicinal plant extracts, long used in traditional malaria treatment, have shown antiplasmodial potential in recent studies. This study investigated the effects of nano tannic acid MgO (NTA MgO) and chloroquine (CQ), both individually and in combination, on a chloroquine-sensitive strain.
BALB/c mice infected with were divided into 11 groups. Groups were treated with NTA MgO (12.5, 25, 50, 100 mg/kg), CQ (1, 3, 10, 20 mg/kg), pure tannic acid (100 mg/kg), or assigned as controls. Peter's method determined the fifty percent effective dose (ED50) for NTA MgO and CQ. Drug interactions were assessed using the fixed-ratio method (ratios: 100/0, 90/10, 70/30, 50/50, 30/70, 10/90, 0/100). Parasitemia and inhibition percentages were calculated and analysed using SPSS software.
The ED values for CQ and NTA MgO were found to be 1.1 mg/kg and 25 mg/kg, respectively. A synergistic effect was observed when a combination of 30% CQ and 70% NTA MgO was used, which significantly reduced parasitemia compared to the control group (P< 0.05, Kruskal-Wallis test). Additionally, NTA MgO administered alone at a dosage of 25 mg/kg effectively reduced the parasite load.
NTA MgO showed strong antiplasmodial activity both alone and with chloroquine (CQ). The 30% CQ and 70% NTA MgO combination exhibited a significant synergistic effect, highlighting its potential as a new treatment for chloroquine-sensitive malaria and the promise of plant-based nanoparticles against drug-resistant malaria.
全球疟原虫对抗疟药物的耐药性不断上升,因此需要新的治疗策略。长期用于传统疟疾治疗的药用植物提取物,在最近的研究中显示出抗疟原虫的潜力。本研究调查了纳米单宁酸氧化镁(NTA MgO)和氯喹(CQ)单独及联合使用对氯喹敏感株的影响。
将感染的BALB/c小鼠分为11组。各组分别用NTA MgO(12.5、25、50、100 mg/kg)、CQ(1、3、10、20 mg/kg)、纯单宁酸(100 mg/kg)治疗,或设为对照组。采用彼得氏法测定NTA MgO和CQ的半数有效剂量(ED50)。使用固定比例法(比例:100/0、90/10、70/30、50/50、30/70、10/90、0/100)评估药物相互作用。使用SPSS软件计算并分析寄生虫血症和抑制百分比。
发现CQ和NTA MgO的ED值分别为1.1 mg/kg和25 mg/kg。当使用30% CQ和70% NTA MgO的组合时,观察到协同效应,与对照组相比,寄生虫血症显著降低(P<0.05,Kruskal-Wallis检验)。此外,单独给予25 mg/kg剂量的NTA MgO可有效降低寄生虫载量。
NTA MgO单独使用以及与氯喹(CQ)联合使用时均显示出强大的抗疟原虫活性。30% CQ和70% NTA MgO的组合表现出显著的协同效应,突出了其作为氯喹敏感型疟疾新治疗方法的潜力,以及植物基纳米颗粒对抗耐药性疟疾的前景。